ClinicalTrials.gov
public full text
Public Domain
Zinc-L-Carnosine Prevents Dysphagia in Breast Cancer Patients Undergoing Adjuvant Radiotherapy
Irradiation of level III and IV draining nodes in breast cancer patients is often associated with dysphagia, requiring treatment with FANS and/or steroids. The present randomized phase III trial determined whether Zinc-L-Carnosine ( Hepilor), prevents or delays the onset of dysphagia in these patients.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Characterization of Immune Evasion Mechanisms of Breast Cancer Disseminated Cells in the Lung#643559
- Neoadjuvant Atezolizumab in Cutaneous Melanoma#1009425
- Phase 0 Study of [18F]MNI-968 as a Marker for D1 Receptor in Healthy Subjects#1137284
- Neoadjuvant Radiotherapy and Immediate Implant-Based Breast Reconstruction#1323298
- Increased Vitamin D Reduces Pulmonary Exacerbations in CF#872273
Record · ID 1261126
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive